| CZR Resources Ltd (CZR) ORDINARY FULLY PAID |
Materials |
$56 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:11AM |
$0.250 |
$0.235 |
fallen by
6%
|
|
CZR - Price-sensitive ASX Announcement
Full Release
Key Points
- CZR completed a positive Pre-Feasibility Study (PFS) for the Robe Mesa iron ore project.
- Initiated a Definitive Feasibility Study (DFS) to advance Robe Mesa.
- Progressed environmental permitting and government approvals for Robe Mesa.
- Continued exploration activities at the Croydon gold project.
- Minimized expenditure on non-core projects and assets.
- Detailed cash flow report covering operations, investing, and financing for the quarter.
- Ended the quarter with a strong cash balance supporting future activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Equatorial Resources Limited (EQX) ORDINARY FULLY PAID |
Materials |
$24 |
June 2025 Quarterly Report
|
31 Jul 2025 9:11AM |
$0.170 |
$0.185 |
risen by
8.82%
|
|
EQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Report covers operational and financial activities for the quarter ending June 2025.
- Focus on iron ore exploration and development projects.
- Updates on project milestones, exploration results, and operational progress.
- Financial position and expenditure summarized for the reporting period.
- Engagement with stakeholders, including regulatory and community relations.
- Discussion of market conditions relevant to iron ore and resource sectors.
- Outline of corporate governance, compliance, and risk management efforts.
- No significant changes in management or corporate structure noted.
- Forward-looking statements on project development and strategic objectives.
- Commitment to sustainable practices and environmental compliance highlighted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$15 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:11AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
SKK - Price-sensitive ASX Announcement
Full Release
Key Points
- Stakk Limited (ASX: SKK) released its Appendix 4C and quarterly activities report for the quarter ended 31 March 2024.
- The company experienced significant growth in group recurring revenue, with annualized recurring revenue increasing from $2.5 million to $2.8 million in the quarter.
- Cash receipts from customers were $1.0 million, reflecting continued adoption and expansion of SKK’s platform.
- Total operating cash outflows were $1.93 million for the quarter, with increased investment in product development and sales activities.
- Stakk signed new contracts with several notable clients, indicating ongoing market traction.
- The company launched new product features, enhancing its core platform and expanding its addressable market.
- SKK continues to focus on customer acquisition and retention strategies, aiming to accelerate growth in the remainder of the financial year.
- Cash and cash equivalents at the end of the quarter totaled $2.0 million, providing a runway for ongoing operations.
- No payments were made to related parties or their associates except for normal remuneration.
- The company remains confident in its growth trajectory and will continue to invest in platform development and business expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities Report
|
31 Jul 2025 9:11AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sunshine Metals Limited released its Quarterly Activities Report for the quarter ending 31 March 2024.
- Drilling and exploration continued at the Liontown, Titov, and New Constitution prospects, with significant gold and copper intercepts.
- The Liontown project remains a focus for resource growth and geological model refinement.
- Exploration activities are generating new targets and extending known mineralisation zones.
- Environmental, social, and governance (ESG) initiatives are actively pursued, including community engagement and safety programs.
- The company maintains a strong cash position to fund ongoing and future exploration activities.
- Operational highlights include positive drilling results and planning for further exploration work in upcoming quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$6 |
June 2025 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:10AM |
$0.008 |
$0.010 |
risen by
25%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- The report covers TRI’s activities and financials for the quarter ending 30 June 2025.
- TrivarX Ltd continued development on key clinical and commercial projects.
- Updates are provided on research and development progress and regulatory submissions.
- The company outlines achieved milestones and sets forth its objectives for the next quarter.
- Appendix 4C summarizes quarterly cash flow, receipts, payments, and cash at the end of the period.
- Financial highlights include funding sources, operating expenses, and runway.
- The report addresses business development efforts and commercial partnerships.
- Commentary is included regarding market and product outlook.
- The company reaffirms its focus on progressing towards regulatory and commercial milestones.
- No significant issues or risks outside of normal business operations are reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$60 |
Investor Presentation - Retraction and Reissue
|
31 Jul 2025 9:10AM |
$0.071 |
$0.074 |
risen by
4.23%
|
|
| Volt Group Limited (VPR) ORDINARY FULLY PAID |
Utilities |
$13 |
Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:10AM |
$0.130 |
$0.125 |
fallen by
3.85%
|
|
VPR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for period ending 30 June 2023.
- Company is focused on its graphite operations in Tanzania (Bunyu Project) and Ukraine (Zavalievsky Graphite).
- Progress in Tanzanian graphite project development and related licensing activities.
- Ukraine graphite business continues amidst ongoing geopolitical instability.
- Exploration of opportunities in battery anode materials and value-added graphite products.
- Continued cost reduction and discipline in operational expenditures.
- Quarter ended with specified cash balance and detailed summary of cash flows.
- Capital raising activities and financing updates provided to shareholders.
- Strategic priorities for the next quarter include advancing project development, enhancing value chains, and financial prudence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rokeby Resources Limited (RKB) ORDINARY FULLY PAID |
Materials |
$18 |
June Quarter Activities and Cash Flow Reports
|
31 Jul 2025 9:09AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
RKB - Price-sensitive ASX Announcement
Full Release
Key Points
- Rokeby Resources Limited (RKB) released its June 2023 Quarterly Activities Report.
- The company advanced exploration activities at its Roe Hills Project, focusing on nickel, gold, and lithium targets.
- Initial soil and rock chip sampling at Roe Hills highlighted several areas with anomalous results.
- Planning for further fieldwork and heritage surveys was ongoing to enable additional exploration.
- During the quarter, RKB completed a maiden drilling program at its Newmont Project, with assay results pending.
- The company continued reviewing new opportunities and project generation activities.
- No mining production or development activities were undertaken during the quarter.
- RKB reported a net cash outflow from operating activities of $183,000, primarily related to exploration and evaluation expenditure.
- The company finished the quarter with a cash balance of $2.44 million.
- Payments to related parties and their associates during the quarter amounted to $65,000, representing director fees and salaries.
- There were no significant changes in business activities or corporate structure reported for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$32 |
Cluey achieves first quarterly positive cash flow result
|
31 Jul 2025 9:09AM |
$0.080 |
$0.092 |
risen by
15%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Cluey Ltd achieved its first ever positive quarterly operating cash flow in Q1 FY24.
- Group receipts from customers were $10.8 million and operating cash flow was $0.2 million.
- Group revenue increased by 14% year-on-year, reaching $10.7 million.
- Contribution Margin for the Group improved to 52% from 47% in the prior corresponding period.
- Cluey ended the quarter with $9.1 million in cash and no debt.
- Strong customer retention and improved marketing efficiency contributed to the positive results.
- Cost reductions and operational efficiencies were key drivers of improved performance.
- Cluey Learning, Code Camp, and Cluey Schools divisions all contributed to growth.
- Strategic focus remains on sustainable profitability through continued revenue growth and disciplined cost management.
- Management expects to maintain positive cash flow in future periods based on current performance and initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MoneyMe Limited (MME) ORDINARY FULLY PAID |
Financials |
$100 |
4Q25 Trading Update - Strong growth and credit performance
|
31 Jul 2025 9:09AM |
$0.138 |
$0.125 |
fallen by
9.09%
|
|
MME - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly loan originations, demonstrating robust demand and market share gains.
- Continued improvement in credit performance, with lower arrears and net losses.
- Growth in the customer base and enhanced digital customer experience.
- Cost management initiatives leading to improved operational efficiencies.
- Diversification of funding sources and reduction in funding costs.
- Strong balance sheet position with prudent capital management.
- Positive outlook for further scaling and profitability supported by technology and innovation.
- Ongoing focus on sustainable, technology-driven lending solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$19 |
Quarterly Activities Report June 2025
|
31 Jul 2025 9:09AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- LIT focused on advancing its lithium battery recycling business (Envirostream), lithium chemicals production through the LieNA® process, and technology development.
- Envirostream increased its battery collection volumes during the quarter, with continued expansion in its collection network and improving processing efficiencies.
- LieNA® pilot plant operations advanced, with the aim of demonstrating continuous production of high-purity lithium chemicals suitable for the battery industry.
- The company made progress in securing regulatory approvals and developing partnerships with industry and government for battery recycling.
- Livium Ltd, a subsidiary, continued to develop and validate its lithium ferro phosphate (LFP) cathode production technology.
- LIT participated in government and industry initiatives to support the circular battery economy and regulatory compliance for battery recycling.
- Financially, LIT maintained prudent expenditure, with a cash position that supports ongoing development activities.
- Future priorities include scaling Envirostream operations, progressing LieNA® commercialisation, and seeking further industry partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$5 |
Update on New Convertible Notes
|
31 Jul 2025 9:08AM |
$0.014 |
$0.013 |
fallen by
7.14%
|
|
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$22 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:08AM |
$0.040 |
$0.037 |
fallen by
7.50%
|
|
DTZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Released Appendix 4C Quarterly Activities and Cash Flow Report for Q1 2023
- Reported advancements in anti-counterfeit, tracing, and diagnostics technologies
- Highlighted commercial agreements and development of DotzMed and DotzProtect platforms
- Continued focus on commercialisation and expansion of sales channels
- Engaged with both new and existing partners for further business opportunities
- Detailed operating cash flows, investments, and cash balance
- Demonstrated prudent financial management to support ongoing operations and growth initiatives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$4 |
Trading Halt
|
31 Jul 2025 9:08AM |
$0.015 |
$0.015 |
fallen by
0%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Imagion Biosystems Limited (IBX) requested a trading halt on 10 July 2023.
- The trading halt is related to an upcoming capital raising announcement.
- Trading will resume either on 12 July 2023 or when the announcement is made.
- The halt ensures an orderly market under ASX Listing Rule 17.1.
- The company aims to prevent trading on an uninformed basis during this period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$229 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:08AM |
$0.455 |
$0.395 |
fallen by
13.19%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Brightstar Resources Limited reported on activities for the quarter ended 31 December 2023.
- Significant progress achieved at the Laverton and Menzies Gold Projects with successful drilling programs resulting in resource growth.
- Completed an oversubscribed $5 million capital raising to fund exploration and development activities.
- Updated resources for Cork Tree Well and Link projects were published, increasing confidence and scale of the projects.
- Technical studies including scoping and feasibility studies commenced for the Laverton Gold Project.
- Closing cash balance of $5.9 million as of 31 December 2023.
- Focus remains on advancing technical studies, further drilling, and resource updates to support a restart of gold production.
- Ongoing engagement with stakeholders and investors to communicate progress and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FINEOS Corporation Holdings PLC (FCL) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$1,033 |
HY25 Result Release Date and Conference Call Details
|
31 Jul 2025 9:07AM |
$2.780 |
$3.050 |
risen by
9.71%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$27 |
Proposed issue of securities - BNL
|
31 Jul 2025 9:07AM |
$0.006 |
$0.008 |
risen by
33.33%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$27 |
Placement to Raise A$4.5 Million
|
31 Jul 2025 9:07AM |
$0.006 |
$0.008 |
risen by
33.33%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Blue Star Helium Limited raises A$4.5 million via placement to institutional, sophisticated, and professional investors.
- Proceeds to fund drilling and development at Voyager helium project in Colorado, as well as working capital and corporate costs.
- Strong support for placement; directors intend to participate subject to shareholder approval.
- Issue price represents a discount to the 5-day volume weighted average price.
- Share Purchase Plan (SPP) to follow for eligible shareholders, aiming to raise up to A$1.5 million.
- Funds will support operational milestones and business development objectives.
- Placement does not require shareholder approval due to available placement capacity.
- The SPP record date and timetable are specified in the announcement.
- Board views the funds raised as critical for near-term growth and execution of strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$208 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:07AM |
$0.320 |
$0.370 |
risen by
15.63%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- Upgraded JORC Resource at Halleck Creek Rare Earth Project to 2.34 billion tonnes at 3,196 ppm TREO.
- Positive preliminary metallurgical test work supports development pathway.
- Scoping Study for Halleck Creek well underway, progressing toward completion.
- Released inaugural Environmental, Social & Governance (ESG) report.
- Completed further drilling and resource definition activities at Halleck Creek.
- Ongoing exploration at the Cowboy State Mine and other Wyoming prospects.
- Appointed new Chief Financial Officer and strengthened management team.
- Quarterly net cash used in operating activities was approximately $2.6 million.
- Cash and cash equivalents at period end were $10.3 million.
- Exploration and evaluation expenditure for the quarter totaled $2.0 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$30 |
Jun 25 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:07AM |
$0.056 |
$0.105 |
risen by
87.50%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report covers operational and financial updates for Rhythm Biosciences Limited.
- ColoSTAT® commercialization and regulatory progress, including CE Mark submission.
- Ongoing activities and strategies for market expansion in Australia, UK, and Europe.
- Key appointments and management commentary on operational progress.
- Financial disclosure includes operating cash outflows and end-of-period cash balance.
- Focus on expenditure, anticipated business milestones, and company funding position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:07AM |
$0.019 |
$0.020 |
risen by
5.26%
|
|
CMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Cosmo Metals Limited released its Quarterly Activities and Appendix 5B Cash Flow Report for the quarter ended 31 March 2023.
- Significant exploration activities were undertaken at the Mt Venn Project in Western Australia, focusing on copper, nickel, and cobalt.
- Drilling at the Mt Venn prospect confirmed significant sulphide zones and a large mineralized system.
- A ground electromagnetic survey at the Eastern Mafic prospect identified new drill targets.
- Exploration and evaluation expenditures were reported for the quarter.
- The company disclosed its cash position at the end of the reporting period.
- Cosmo Metals maintains a focus on advancing exploration and technical programs while managing finances prudently.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$771 |
Net Tangible Asset Backing
|
31 Jul 2025 9:06AM |
$2.370 |
$2.390 |
risen by
0.84%
|
|
| Astron Corporation Limited (ATR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$142 |
Appendix 5B - Quarterly Cash Flows - 30 June 2025
|
31 Jul 2025 9:06AM |
$0.610 |
$0.680 |
risen by
11.48%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report for the period ended 30 June 2025.
- Breakdown of operating, investing, and financing cash activities.
- Disclosures on receipts from customers and payments for exploration and evaluation.
- Details of payments to staff, administration, and corporate costs.
- Statement of cash at the beginning and end of the quarter.
- Details of related party payments and director remuneration.
- Narrative updates on exploration projects and corporate developments.
- Compliance statements with Australian Securities Exchange (ASX) requirements.
- Directors’ assertion of sufficient working capital for ongoing operations.
- Summary of future planned cash outflows and funding requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$353 |
Preliminary Final Results
|
31 Jul 2025 9:06AM |
$1.125 |
$1.120 |
fallen by
0.44%
|
|
AMH - Price-sensitive ASX Announcement
Full Release
Key Points
- AMCIL Limited reported its Preliminary Final Results for the year ended 30 June 2024.
- The company invests primarily in quality Australian listed securities with a long-term investment horizon.
- Portfolio returns and net asset value performance were discussed, highlighting key contributors and detractors.
- Dividend payments for shareholders were outlined, including franked dividends.
- The report described AMCIL's investment process, emphasizing quality, value, and sustainable returns.
- Market conditions and economic factors affecting investment performance were analyzed.
- Risk management strategies and portfolio diversification practices were outlined.
- The company provided commentary on portfolio changes and significant investment decisions during the period.
- AMCIL expressed an ongoing commitment to delivering sustainable capital and dividend growth.
- The outlook section addressed expectations for the upcoming financial year, referencing market uncertainties and opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$15 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:06AM |
$0.022 |
$0.014 |
fallen by
36.36%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- NTI reported progress in its clinical programs, especially targeting ASD with its NTI164 drug candidate.
- Positive clinical trial results reinforce the potential of NTI164 for pediatric neurological conditions.
- Further clinical trials, regulatory submissions, and commercialisation activities are planned.
- Financial report covers grant receipts, R&D tax incentives, operational costs, and quarter-end cash balance.
- Company remains focused on prudent cash management and achieving clinical development milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
